Report cover image

Genitourinary Drugs Global Market Report 2025

Published Jul 07, 2025
Length 175 Pages
SKU # BRC20166059

Description

Genitourinary Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genitourinary drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for genitourinary drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genitourinary drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product: Urologicals; Hormonal Therapy; Gynecological; Anti-Infectives; Other Products

2) By Route Of Administration: Oral; Parenteral; Topical

3) By Application: Urinary Tract Infections (UTIs); Benign Prostatic Hyperplasia (BPH); Prostate Cancer; Overactive Bladder; Bladder Cancer; Other Applications

4) By Distribution Channel: Hospital Pharmacies; Drug Store And Retail Pharmacies; Online Pharmacies

Subsegments:

1) By Urologicals: Benign Prostatic Hyperplasia (BPH) Drugs; Urinary Incontinence Drugs; Overactive Bladder (OAB) Drugs; Urolithiasis (Kidney Stone) Drugs; Erectile Dysfunction Drugs

2) By Hormonal Therapy: Estrogen Therapy; Progestin Therapy; Gonadotropin-Releasing Hormone (GnRH) Agonists/Antagonists; Androgen Replacement Therapy; Selective Estrogen Receptor Modulators (SERMs)

3) By Gynecological: Contraceptives; Menopausal Hormone Therapy; Fertility Drugs; Drugs for Endometriosis; Drugs for Polycystic Ovary Syndrome (PCOS)

4) By Anti-Infectives: Urinary Tract Infection (UTI) Drugs; Sexually Transmitted Infection (STI) Drugs; Vaginal Antifungals; Antivirals

5) By Other Products: Drugs for Chronic Pelvic Pain; Bladder Cancer Therapies; Interstitial Cystitis Drugs; Pelvic Organ Prolapse Treatment Drugs; Adjunctive Therapies

Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; Bayer AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Genitourinary Drugs Market Characteristics
3. Genitourinary Drugs Market Trends And Strategies
4. Genitourinary Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Genitourinary Drugs Growth Analysis And Strategic Analysis Framework
5.1. Global Genitourinary Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Genitourinary Drugs Market Growth Rate Analysis
5.4. Global Genitourinary Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Genitourinary Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Genitourinary Drugs Total Addressable Market (TAM)
6. Genitourinary Drugs Market Segmentation
6.1. Global Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Urologicals
Hormonal Therapy
Gynecological
Anti-Infectives
Other Products
6.2. Global Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Topical
6.3. Global Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Urinary Tract Infections (Utis)
Benign Prostatic Hyperplasia (BPH)
Prostate Cancer
Overactive Bladder
Bladder Cancer
Other Applications
6.4. Global Genitourinary Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Drug Store And Retail Pharmacies
Online Pharmacies
6.5. Global Genitourinary Drugs Market, Sub-Segmentation Of Urologicals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Benign Prostatic Hyperplasia (BPH) Drugs
Urinary Incontinence Drugs
Overactive Bladder (OAB) Drugs
Urolithiasis Drugs
Erectile Dysfunction Drugs
6.6. Global Genitourinary Drugs Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Estrogen Therapy
Progestin Therapy
Gonadotropin-Releasing Hormone (GnRH) Agonists/Antagonists
Androgen Replacement Therapy
Selective Estrogen Receptor Modulators (SERMs)
6.7. Global Genitourinary Drugs Market, Sub-Segmentation Of Gynecological, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Contraceptives
Menopausal Hormone Therapy
Fertility Drugs
Drugs For Endometriosis
Drugs For Polycystic Ovary Syndrome (PCOS)
6.8. Global Genitourinary Drugs Market, Sub-Segmentation Of Anti-Infectives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Urinary Tract Infection (UTI) Drugs
Sexually Transmitted Infection (STI) Drugs
Vaginal Antifungals
Antivirals
6.9. Global Genitourinary Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drugs For Chronic Pelvic Pain
Bladder Cancer Therapies
Interstitial Cystitis Drugs
Pelvic Organ Prolapse Treatment Drugs
Adjunctive Therapies
7. Genitourinary Drugs Market Regional And Country Analysis
7.1. Global Genitourinary Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Genitourinary Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Genitourinary Drugs Market
8.1. Asia-Pacific Genitourinary Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Genitourinary Drugs Market
9.1. China Genitourinary Drugs Market Overview
9.2. China Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Genitourinary Drugs Market
10.1. India Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Genitourinary Drugs Market
11.1. Japan Genitourinary Drugs Market Overview
11.2. Japan Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Genitourinary Drugs Market
12.1. Australia Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Genitourinary Drugs Market
13.1. Indonesia Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Genitourinary Drugs Market
14.1. South Korea Genitourinary Drugs Market Overview
14.2. South Korea Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Genitourinary Drugs Market
15.1. Western Europe Genitourinary Drugs Market Overview
15.2. Western Europe Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Genitourinary Drugs Market
16.1. UK Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Genitourinary Drugs Market
17.1. Germany Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Genitourinary Drugs Market
18.1. France Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Genitourinary Drugs Market
19.1. Italy Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Genitourinary Drugs Market
20.1. Spain Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Genitourinary Drugs Market
21.1. Eastern Europe Genitourinary Drugs Market Overview
21.2. Eastern Europe Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Genitourinary Drugs Market
22.1. Russia Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Genitourinary Drugs Market
23.1. North America Genitourinary Drugs Market Overview
23.2. North America Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Genitourinary Drugs Market
24.1. USA Genitourinary Drugs Market Overview
24.2. USA Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Genitourinary Drugs Market
25.1. Canada Genitourinary Drugs Market Overview
25.2. Canada Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Genitourinary Drugs Market
26.1. South America Genitourinary Drugs Market Overview
26.2. South America Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Genitourinary Drugs Market
27.1. Brazil Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Genitourinary Drugs Market
28.1. Middle East Genitourinary Drugs Market Overview
28.2. Middle East Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Genitourinary Drugs Market
29.1. Africa Genitourinary Drugs Market Overview
29.2. Africa Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Genitourinary Drugs Market Competitive Landscape And Company Profiles
30.1. Genitourinary Drugs Market Competitive Landscape
30.2. Genitourinary Drugs Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
31. Genitourinary Drugs Market Other Major And Innovative Companies
31.1. Novartis AG
31.2. Sanofi S.A.
31.3. Bristol Myers Squibb
31.4. AstraZeneca plc
31.5. Abbott Laboratories
31.6. GSK plc
31.7. Eli Lilly and Company
31.8. Amgen Inc.
31.9. Teva Pharmaceutical Industries Ltd.
31.10. Astellas Pharma Inc.
31.11. Ipsen Société Anonyme
31.12. Aurobindo Pharma Limited
31.13. Dr. Reddy's Laboratories Limited
31.14. Cipla Limited
31.15. Hikma Pharmaceuticals Public Limited Company
32. Global Genitourinary Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Genitourinary Drugs Market
34. Recent Developments In The Genitourinary Drugs Market
35. Genitourinary Drugs Market High Potential Countries, Segments and Strategies
35.1 Genitourinary Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Genitourinary Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Genitourinary Drugs Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.